Interesting study on cost effectiveness of 6-monthly Covid booster programs in England, concluding
"only universal programmes that target those above 70 years old are likely to be cost effective"
(noting lower age thresholds for those who are immunosuppressed)
[1/n]
"only universal programmes that target those above 70 years old are likely to be cost effective"
(noting lower age thresholds for those who are immunosuppressed)
[1/n]
Reposted from
Ed Hill
📄 Now published in Vaccine, "Cost-effectiveness of routine COVID-19 adult vaccination programmes in England" #IDSky #IDEpi
✍️ @mattkeeling.bsky.social, @edmhill.bsky.social, S Petrou, PB Tran, ME Png, S Staniszewska, @corinnaclark.bsky.social, K Hassel, J Stowe, N Andrews
🔗: doi.org/10.1016/j.va...
✍️ @mattkeeling.bsky.social, @edmhill.bsky.social, S Petrou, PB Tran, ME Png, S Staniszewska, @corinnaclark.bsky.social, K Hassel, J Stowe, N Andrews
🔗: doi.org/10.1016/j.va...
Comments
- Only accounts for direct protection, not indirect benefits of reducing transmission.
- Only accounts for costs ($+QALYs) of hospital/ICU admissions and deaths, not impacts of less severe disease, post-acute illness, etc.
- Will depend on size, timing, severity and VE for future wave